Evidence map›Paper›PMID 42836504›Full record

ArticleCurrent drug metabolism2026

The Metabolites of Secoiridoid Enantiomers and Diastereomers with 9-Carbon Skeleton in

Yaomin Wang, Ye Yang, Huanhuan Fu, Fakai Mi, Fang Wang, Li Wang, Haiyu Feng, Zhenggang Yue, Yihan He

Abstract read
PubMed Publisher
In one paragraph

Article in Current drug metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yaomin WangState Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Provincial Collaborative Innovation Center for the Industrialization of Traditional Chinese Medicine Resources, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, P.R. China.ORCID 0009-0003-7327-917X
Ye YangState Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Provincial Collaborative Innovation Center for the Industrialization of Traditional Chinese Medicine Resources, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, P.R. China.ORCID 0000-0003-2536-4276
Huanhuan FuState Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Provincial Collaborative Innovation Center for the Industrialization of Traditional Chinese Medicine Resources, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, P.R. China.ORCID 0000-0002-5765-9485
Fakai MiCollege of Life Science, Qinghai Normal University, Xining 810016, P.R. China.ORCID 0009-0008-9864-554X
Fang WangState Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Provincial Collaborative Innovation Center for the Industrialization of Traditional Chinese Medicine Resources, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, P.R. China.ORCID 0009-0006-1397-2548
Li WangState Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Provincial Collaborative Innovation Center for the Industrialization of Traditional Chinese Medicine Resources, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, P.R. China.ORCID 0009-0009-3162-803X
Haiyu FengState Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Provincial Collaborative Innovation Center for the Industrialization of Traditional Chinese Medicine Resources, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, P.R. China.ORCID 0009-0005-6406-7954
Zhenggang YueState Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Provincial Collaborative Innovation Center for the Industrialization of Traditional Chinese Medicine Resources, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, P.R. China.ORCID 0000-0001-6296-8509
Yihan HeState Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Provincial Collaborative Innovation Center for the Industrialization of Traditional Chinese Medicine Resources, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, P.R. China.ORCID 0000-0001-9772-6921

Funding

Key Industry Innovation Chain (Group) of Shaanxi Province 2023-ZDLSF-58Key Program (A) of Shaanxi Provincial Health Commission 2021A008Key Research and Development Program of Shaanxi Province 2022SF-089Natural Science Foundation of China 81903753Natural Science Foundation of Qinghai 2022-ZJ-917Project on Collaborative Innovation of Shaanxi Provincial Department of Education 21JY011, 23JY024
6 · The paper itself

Abstract

introductionThe secoiridoid metabolites with a 10-carbon skeleton, such as gentiopicroside, swertiamarin, and sweroside, were identified as the main components in Gentiana macrophylla. However, various unpredictable rearrangement metabolites might be generated due to the high reactivity of the hemiacetal in their structures. Thus, our ongoing research aimed to explore additional metabolites with new carbon skeleton features from G. macrophylla.

methodsMetabolites were separated and purified using multi-chromatographic techniques, such as silica gel, HP-20 resin gel, LH-20 dextran gel, C18 gel, and chiral CHIRALPAK AD-H column chromatography; and characterized by multi-spectroscopic methods, including NMR and X-ray spectroscopy, experimental CD measurement compared with ECD calculation, and carbon NMR calculation. Moreover, their biosynthetic pathways were deduced according to the KEGG pathway and their correlations with normal secoiridoid metabolites in G. macrophylla.

resultsA pair of norsecoiridoid diastereomers, (3R, 6R, 8S)-3-methoxy-6-hydroxy-swerimuslactone A (1) and (3S, 6R, 8R)-3-methoxy-6-hydroxy-swerimuslactone A (2), were isolated and identified from G. macrophylla, along with two pairs of racemates (3) and (4) with [α]²⁰_D = 0. These racemates were further separated by chiral column chromatography into two pairs of norsecoiridoid enantiomers: (-)-(5S, 8S)- gentimaclactone A (3a) and (+)-(5R, 8R)-gentimaclactone A (3b), and (+)-(3S, 8R)-swerimilegenin E (4a) and (-)-(3R, 8S)-swerimilegenin E (4b), respectively. DISCUSSION: All compounds were determined to have a 9-carbon skeleton, derived from the normal 10- carbon secoiridoids in G. macrophylla. Their biosynthetic pathways were deduced to occur via ring-opening of the hemiacetal at C-1, ring-closing with the hydroxyl group at C-8, followed by degradation of a CHO group.

conclusionFour norsecoiridoids with a 9-carbon skeleton, derived from the normal 10-carbon secoiridoids, were isolated from G. macrophylla. They were present as pairs of diastereomers or racemates, which were further separated into pairs of enantiomers. Among them, the diastereomer pair (3R, 6R, 8S)- 3-methoxy-6-hydroxy-swerimuslactone A (1) and (3S, 6R, 8R)-3-methoxy-6-hydroxy-swerimuslactone A (2), and the enantiomer pair (-)-(5S, 8S)-gentimaclactone A (3a) and (+)-(5R, 8R)-gentimaclactone A (3b) were identified as new compounds. Additionally, the plausible biosynthetic pathways of these compounds were proposed for future studies.

Indexed as

GentianaIridoidsIridoid GlucosidesStereoisomerismgentiopicrosideIridoid GlucosidesIridoidsdiastereomersenantiomersGentiana macrophylla pallisolationnorsecoiridoidsstereochemistrythe plausible pathway

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.